NCT02128646View on ClinicalTrials.gov

Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Pain
Interventions
DRUG

EXPAREL

DRUG

Ketorolac

PROCEDURE

laparoscopic abdominal hernia repair

PROCEDURE

an open surgery for abdominal hernia repair

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

University of Kansas Medical Center

OTHER